Exploring Opportunities of Glucose Excipient Market: Comprehensive Analysis of Industry Dynamics, Applications, Regulatory Landscape, Competitive Scenario, and Future Growth Prospects 2031 | DFE Pharma, Gulshan Polyols Ltd., Tereos Group

Market Overview:

Glucose excipients are commonly used as filler and diluent in pharmaceutical drug formulations. They provide bulk to tablets and aid in controlling drug release from extended or sustained release formulations.

The global glucose excipient market size was valued at US$ 1,058.2 million in 2023 and is projected to reach US$ 1,328.1 million by 2030, growing at a CAGR of 3.3% from 2023 to 2030.

Market Dynamics:

Glucose excipients find widespread application in solid oral dosage forms such as tablets and capsules. Additionally, rising demand for biopharmaceuticals is facilitating the growth of the glucose excipient market. Biopharmaceutical products often utilize glucose excipients to stabilize proteins and control osmotic activity for subcutaneous or intramuscular delivery. Growing biologics market is therefore propelling market growth. Furthermore, glucose excipients aid in regulating drug release from modified or sustained release formulations. Increasing focus on developing extended release drugs is augmenting the demand for glucose excipients over the forecast period.

Request Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/5857

List of TOP Players in Market Report are: -

◘ Roquette Frères
◘ Cargill
◘ Incorporated
◘ Ingredion
◘ ADM
◘ Merck KGaA
◘ DFE Pharma
◘ Gulshan Polyols Ltd.
◘ Tereos Group
◘ Tate & Lyle PLC and ungbunzlauer Suisse AG

Note: Major Players are sorted in no particular order.

Market Detailed Segmentation:

By Type: Dextrose Monohydrate, Anhydrous Dextrose, Specialty Glucose Variants
By Form: Powdered Glucose, Crystalline Glucose, Liquid Glucose
By Function: Fillers & Binders, Diluents, Disintegrants, Others
By Application: Pharmaceuticals, Cosmeceuticals
By End User: Pharmaceutical and Biotechnology Companies, Cosmeceuticals Companies

Driver: Growing prevalence of diabetes disease across the globe

The prevalence of diabetes disease has been increasing tremendously over the past few decades. As per WHO, the number of people with diabetes raised from 108 million in 1980 to 422 million in 2014. Diabetes currently affects over 8.5% of adults worldwide and is a major cause of blindness, kidney failure, heart attacks, strokes and lower limb amputation. With rising obesity rates and increasingly sedentary lifestyles, the incidence of diabetes is growing in most countries. Glucose is commonly used as an excipient in various formulations to treat diabetes. Oral anti-diabetic drugs often contain glucose as an excipient to control blood sugar levels. Continuous growth in the diabetic population will further drive the demand for glucose excipients globally in the coming years.

Glucose finds widespread applications as an excipient in many pharmaceutical dosage forms including tablets, capsules, solutions, suspensions, ointments etc. It is widely used as a filler-binder, sweetening agent, taste masking agent and bulking agent in oral solid dosage forms. Glucose also acts as a soothing agent and humectant in topical formulations. Moreover, due to its small molecular size and water solubility, glucose is frequently chosen as a diluent in injectable solutions. Its versatile functional properties allow glucose to be utilised across diverse drug delivery systems. Growing uptake of innovative drug delivery technologies is further augmenting the usage of glucose excipient. Continued growth in dosage form complexities and drug pipeline will maintain the need for multifunctional excipients like glucose.

Restrain: Stringent regulatory norms

The pharmaceutical excipients market is highly regulated by authorities like US FDA, EMA etc. These regulatory bodies impose stringent manufacturing and quality norms to ensure excipients safety, efficacy and consistency. Any change in the grade or source of excipient requires extensive documentation and approval. Regulatory delays in approval of new excipients or facility expansions pose challenges. The regulatory framework also restricts the use of certain excipients based on their side effects. Additionally, global harmonization of excipient monographs remains an ongoing process increasing complexity. The evolving regulatory landscape pressures manufacturers to invest in R&D, quality systems and personnel training to ensure compliance. This impacts commercialization timelines and raises overall costs of excipient production.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/5857

Opportunity: Customized formulation development

With growing patient demands, the focus in pharmaceutical industry is shifting towards development of customized or personalized formulations. Various segments like geriatric, pediatric and orphan drug products require specialized excipients suited for particular patient populations. This presents an opportunity for glucose excipient manufacturers to develop customized grades catering to unique formulation needs. Emerging areas like 3D printing of solid oral drugs also warrant novel excipients with properties like printability and stability. Development of tailor-made glucose grades having attributes like controlled release, taste masking etc will help spur innovation. Collaboration with drug makers in preformulation studies can help identify novel application areas. Customized glucose products will enhance formulation uniqueness giving competitive edge over commodity grades.

Trend: Increasing adoption of multifunctional excipients

Pharmaceutical industries constantly strive for simpler, cost-effective formulations with multifunctional ingredients. Traditionally excipients served single roles but now multifunctional excipients having 2-3 functionalities are gaining traction. Glucose exhibits multiple functional properties and has potential to act as multifunctional excipient. Ongoing research studies are exploring new applications of glucose derivatives with enhanced capabilities. For example, methylated or hydroxypropylated glucose derivatives exhibiting sustained release properties. Novel glucose complexes with metals/minerals also give controlled delivery. Growing need for space and cost efficiencies in drug product design will promote adoption of such multifunctional excipients like customized glucose grades. This trend allows formulators to reduce ingredient lists using single multifaceted components.

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2022
The base year for estimation - is 2022
Estimated Year - 2024
Forecast period** - 2024 to 2031

This Glucose Excipient Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the Glucose Excipient market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the Glucose Excipient market, and what are the emerging Market applications and trends?

◈ What are the projections for the global Glucose Excipient Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of Glucose Excipient , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of Glucose Excipient in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Glucose Excipient Market?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5857

Summarized Extracts from TOC of Market Study

Chapter 1 Glucose Excipient Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Glucose Excipient

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Glucose Excipient industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Glucose Excipient Market Analysis by Countries

Chapter 9 Asia Pacific Glucose Excipient Market Analysis by Countries

Chapter 10 Middle East and Africa Glucose Excipient Market Analysis by Countries

Chapter 11 South America Glucose Excipient Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.